Pharmaceutical NEWS
Text size:
T
T
T
Maryland Dialysis Center Prepares for Tag-Implantation Project
The Independent Dialysis Foundation hopes the trial, carried out in conjunction with VeriChip, will help spare its patients from unnecessary procedures and medications.
By Beth Bacheldor
Sept. 3, 2007—Independent Dialysis Foundation (IDF), a not-for-profit operator of dialysis centers in Maryland, has teamed with VeriChip to test the implantation of RFID chips in its patients to make it easier to access their health records during an emergency.
Located in Delray Beach, Fla., VeriChip makes the VeriMed patient identification system, consisting of RFID interrogators and 134 kHz RFID tags compliant with the ISO 11784 and 11785 standards, as well as associated software and a VeriChip-hosted patient information database. Encased in glass and about the size of a rice grain, the tags are designed to be implanted, via syringe, just under the skin of a patients' arm. Each tag is encoded with a unique 16-digit ID number, which is associated with the patient's medical records stored in the VeriChip-hosted database.
When a patient visits a hospital equipped with the VeriMed system, personnel can read that individual's unique ID number by waving an interrogator over the general area of the implanted chip, then accessing the secure database containing the patient's identity and medical information. The project is designed to test the functionality of the RFID implant in real-life scenarios.
"Many dialysis patients have chronic diseases. Many are diabetic, and many have cardiac disease such as hypertension. And because of that, they often have medical emergencies that put then in the ER," says Dr. John Sadler, CEO and founder of IDF, which is affiliated with the University of Maryland and serves about 500 patients in eight outpatient centers and four hospitals throughout Maryland. "One of our biggest problems is that they go to ER, but there isn't medical history easily available, and the patients can't always provide it, so the staff does things there that are not needed and not appropriate for the care of [that] patient."
more Pharmaceutical articles
Sept. 3, 2007—Independent Dialysis Foundation (IDF), a not-for-profit operator of dialysis centers in Maryland, has teamed with VeriChip to test the implantation of RFID chips in its patients to make it easier to access their health records during an emergency.
Located in Delray Beach, Fla., VeriChip makes the VeriMed patient identification system, consisting of RFID interrogators and 134 kHz RFID tags compliant with the ISO 11784 and 11785 standards, as well as associated software and a VeriChip-hosted patient information database. Encased in glass and about the size of a rice grain, the tags are designed to be implanted, via syringe, just under the skin of a patients' arm. Each tag is encoded with a unique 16-digit ID number, which is associated with the patient's medical records stored in the VeriChip-hosted database.
When a patient visits a hospital equipped with the VeriMed system, personnel can read that individual's unique ID number by waving an interrogator over the general area of the implanted chip, then accessing the secure database containing the patient's identity and medical information. The project is designed to test the functionality of the RFID implant in real-life scenarios.
"Many dialysis patients have chronic diseases. Many are diabetic, and many have cardiac disease such as hypertension. And because of that, they often have medical emergencies that put then in the ER," says Dr. John Sadler, CEO and founder of IDF, which is affiliated with the University of Maryland and serves about 500 patients in eight outpatient centers and four hospitals throughout Maryland. "One of our biggest problems is that they go to ER, but there isn't medical history easily available, and the patients can't always provide it, so the staff does things there that are not needed and not appropriate for the care of [that] patient."
